Earnings ·
Sotera Health Company reported second-quarter 2026 net income of $54 million ($0.19 per diluted share), up from $8…
SHCSotera Health Co
Sotera Health Company reported second-quarter 2026 net income of $54 million ($0.19 per diluted share), up from $8 million in the prior year period, driven by high-single-digit revenue growth across its business units. The company raised its full-year 2026 outlook, projecting net revenues to grow 5.25% to 6.75% and Adjusted EBITDA to grow 5.75% to 7.25%, on a constant currency basis. Management cited strong execution in Sterigenics, Nordion, and Nelson Labs, alongside improved liquidity with approximately $950 million available and a net leverage ratio of 3.0x. Sotera Health operates as a leading global provider of mission-critical end-to-end sterilization solutions, lab testing, and advisory services for the healthcare industry.